Age | Suspected drug | Reaction | ||
3 mth | DTP Hib and polio | Depressed level of consciousness | ||
8 y | Fluticasone3-150 | Adrenal suppression | ||
7 y | Fluticasone3-150 | Adrenal suppression | ||
2 y | Interferon alfa | Motor development impaired | ||
1 y | Diamorphine | Stevens–Johnson syndrome | ||
1 wk | Baclofen | Neonatal convulsion | ||
11 y | Vigabatrin3-150 | Visual disturbance | ||
11 mth | Bupivacaine | Supraventricular tachycardia | ||
Ventricular fibrillation | ||||
11 y | Cephradine | Anaphylactic reaction | ||
9 y | Carbamazepine | Hypovolaemia | ||
Renal failure, acute | ||||
8 y | Cyclosporin | Colitis | ||
4 mth | DTP vaccine | Convulsions | ||
13 y | Fluticasone nasal spray3-150 | Benign intracranial hypertension | ||
6 y | Diclofenac | Haematemesis | ||
15 y | Lansoprazole | Neutropenia | ||
4 y | Fluticasone3-150 | Adrenal suppression | ||
Hypoglycaemic convulsion | ||||
4 mth | DTP Hib | Convulsions | ||
1 day | Atracurium | Acute circulatory failure | ||
Apnoea | ||||
Convulsions | ||||
Disseminated intravascular coagulation | ||||
Hypoglycaemia | ||||
Metabolic acidosis |
↵3-150 Reports for these drugs were specifically requested in monthly reminder letters.